Monograph Capital: Investment Portfolio & Startup News
Monograph Capital
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
RQ Bio
25 Jun 2026
RQ Bio raises a £86m Series A led by Frazier Life Sciences to develop long-acting antibody protection against seasonal influenza
RQ Bio is a UK-based biotechnology company developing long-acting monoclonal antibodies against seasonal influenza. Its lead programme, RQB01, is designed to deliver potent, broad-strain protection against influenza through a dual mechanism of action, targeting patients whose immune systems cannot rely on vaccination alone.
Elevara Medicines
22 Oct 2025
Elevara raises £50m Series A led by Forbion and Sofinnova Partners to develop therapies for rheumatoid arthritis
Elevara develops oral therapies for rheumatoid arthritis by targeting synovial fibroblasts rather than the immune system, aiming to improve remission rates in chronic inflammatory disease.
Monograph Capital
- 1(12 months)
- monograph.bio
- Update Information
More venture news
- 2 Nov 2026
LO:TECHLO:TECH secures a £9m Series A round led by MMC to build a 24/7 trading firm for traditional, digital and onchain markets
Series AFintech - 28 Oct 2026
Circuit MindCircuit Mind raises £19m including a Series A round led by Norwest to design and check circuit boards automatically
Series AIndustrial - 26 Oct 2026
adsilicoadsilico unlocks a £10m Series A round led by PXN Ventures for virtual testing of implantable medical devices
Series ALife Sciences
